Trial
NCT06056596
Lamivudine and Plasma Markers of Inflammation in Retinal Detachment
Early Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Wisconsin, Madison
Collaborators
—
Condition
Retinal Detachment
Intervention
Lamivudine 300 MG
Why stopped
Treatment approach changed, and insufficient population
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-09-19